Ylenia Cendón

PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer

Elena Castro, Nuria Romero-Laorden, Ángela del Pozo et al. · Journal of Clinical Oncology · 2019 · 366 citations · Full text

mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

Amaia Zabala‐Letona, Amaia Arruabarrena-Aristorena, Natalia Martín-Martín et al. · Nature · 2017 · 210 citations · Full text

Urology, Medicine, Mtorc1-dependent Amd1 Regulation +4

PARP‐1 regulates DNA repair factor availability

Matthew J. Schiewer, Amy C. Mandigo, Nicolas Gordon et al. · EMBO Molecular Medicine · 2018 · 78 citations · Full text

HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies

Daniel Khalaf, Isabel M. Aragón, Matti Annala et al. · Annals of Oncology · 2020 · 43 citations · Full text

Urology, Prospective Studies, Health Sciences +10

Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)

Nuria Romero-Laorden, Rebeca Lozano, Anuradha Jayaram et al. · British Journal of Cancer · 2018 · 42 citations · Full text